120 related articles for article (PubMed ID: 22307528)
1. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma.
Xu BJ; An QA; Srinivasa Gowda S; Yan W; Pierce LA; Abel TW; Rush SZ; Cooper MK; Ye F; Shyr Y; Weaver KD; Thompson RC
Int J Oncol; 2012 Jun; 40(6):1995-2003. PubMed ID: 22307528
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.
Song L; Liu L; Wu Z; Lin C; Dai T; Yu C; Wang X; Wu J; Li M; Li J
J Pathol; 2012 Feb; 226(3):534-43. PubMed ID: 21960069
[TBL] [Abstract][Full Text] [Related]
3. Identification of expressed genes characterizing long-term survival in malignant glioma patients.
Yamanaka R; Arao T; Yajima N; Tsuchiya N; Homma J; Tanaka R; Sano M; Oide A; Sekijima M; Nishio K
Oncogene; 2006 Sep; 25(44):5994-6002. PubMed ID: 16652150
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
Weng W; Chen X; Gong S; Guo L; Zhang X
Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
Zhang R; Pang B; Xin T; Guo H; Xing Y; Xu S; Feng B; Liu B; Pang Q
Mol Neurobiol; 2016 Apr; 53(3):1452-1460. PubMed ID: 25636684
[TBL] [Abstract][Full Text] [Related]
8. Identification of gliotropic factors that induce human stem cell migration to malignant tumor.
An JH; Lee SY; Jeon JY; Cho KG; Kim SU; Lee MA
J Proteome Res; 2009 Jun; 8(6):2873-81. PubMed ID: 19351187
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
10. ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome.
Lu S; Niu N; Guo H; Tang J; Guo W; Liu Z; Shi L; Sun T; Zhou F; Li H; Zhang J; Zhang B
Eur J Cancer; 2013 Feb; 49(3):752-63. PubMed ID: 23063350
[TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
Lai NS; Wu DG; Fang XG; Lin YC; Chen SS; Li ZB; Xu SS
Br J Cancer; 2015 Mar; 112(7):1241-6. PubMed ID: 25756397
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
14. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
[TBL] [Abstract][Full Text] [Related]
15. Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas.
Ishiwata T; Teduka K; Yamamoto T; Kawahara K; Matsuda Y; Naito Z
Oncol Rep; 2011 Jul; 26(1):91-9. PubMed ID: 21503585
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of PCDH9 predicts prognosis for patients with glioma.
Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth.
Kumar DM; Thota B; Shinde SV; Prasanna KV; Hegde AS; Arivazhagan A; Chandramouli BA; Santosh V; Somasundaram K
J Proteome Res; 2010 Nov; 9(11):5557-67. PubMed ID: 20822092
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
